For those of you in the UK who are seeking access to a Tinnitus drug, your chance may be at hand. Autifony Therapeutics is conducting phase 2 of a study they’re calling QUIET-1.
In phase 2 of this study, they’re comparing the effect of the new AUT00063 drug to a placebo (dummy drug) after four weeks of treatment. The phase I safety trial is complete and was well tolerated in young and older healthy volunteers with no serious adverse effects being noted.
AUT00063 is an orally active preparation that will be taken as 4 capsules once daily with food, for a period of 4 weeks.
Below are the clinics and hospitals currently participating in the trial. Hopefully, one is close to you.
More information about the trials can be found at this link.